{"id":"NCT02283268","sponsor":"Baxalta now part of Shire","briefTitle":"Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery","officialTitle":"A Phase 3, Prospective, Multicenter Study to Evaluate Efficacy and Safety of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Elective Surgical Procedures in Subjects With Severe Von Willebrand Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-04-01","primaryCompletion":"2016-07-06","completion":"2016-07-06","firstPosted":"2014-11-05","resultsPosted":"2017-08-31","lastUpdate":"2021-05-19"},"enrollment":24,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Von Willebrand Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Recombinant von Willebrand Factor (rVWF)","otherNames":[]}],"arms":[{"label":"Recombinant von Willebrand Factor (rVWF)","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to assess the efficacy and safety of recombinant von Willebrand factor (rVWF) with or without ADVATE in major and minor elective surgical procedures in adult patients with hereditary severe von Willebrand disease (VWD).","primaryOutcome":{"measure":"Overall Hemostatic Efficacy as Assessed by the Investigator (Hemophilia Physician)","timeFrame":"24 hours after last peri-operative infusion or at completion of Day 14 (± 2 days) visit, whichever occurs earlier","effectByArm":[{"arm":"Recombinant Von Willebrand Factor (rVWF)","deltaMin":11,"sd":null},{"arm":"Minor Surgery","deltaMin":4,"sd":null},{"arm":"Major Surgery","deltaMin":7,"sd":null},{"arm":"Oral Surgery","deltaMin":0,"sd":null},{"arm":"Von Willebrand Disease Type 1","deltaMin":2,"sd":null},{"arm":"Von Willebrand Disease Type 2A","deltaMin":1,"sd":null},{"arm":"Von Willebrand Disease Type 2B","deltaMin":1,"sd":null},{"arm":"Von Willebrand Disease Type 2M","deltaMin":0,"sd":null},{"arm":"Von Willebrand Disease Type 3","deltaMin":7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":18},"locations":{"siteCount":34,"countries":["United States","Australia","Austria","Czechia","Germany","Italy","Netherlands","Russia","Spain","Taiwan","Turkey (Türkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":15},"commonTop":["Acne","Dry skin","Iron deficiency anaemia","Peripheral swelling","Nasopharyngitis"]}}